New Healios® Supplement From Enlivity Offers Relief for Oral Mucositis

Share Article

Enlivity introduces Healios®, an oral mucositis dietary supplement that fights dry mouth to ease the pain of eating and swallowing, which is a common side effect of cancer treatments.

:    Boston, Mass., July 17, 2018 — Today, medical nutrition company Enlivity announces the availability of Healios®, a dietary supplement for oral mucositis shown to be clinically effective in abating mouth sores and their discomfort during cancer treatment. Healios was developed from research pioneered by Dr. Peter Anderson, while serving as Curtis Distinguished Professor, at The University of Texas, MD Anderson Cancer Center in Houston, Texas.

Dr. Anderson, currently a Professor at the Cleveland Clinic, wanted to find a solution for relieving the discomfort associated with damage to the epithelial cells lining the mouth, throat, esophagus and digestive tract caused by cancer treatment. Some patients are unable to eat or drink sufficiently to complete their treatments because the pain is so severe. Before this breakthrough, managing the pain and infection from mouth sores were the best available treatment options.

"We found that by combining glutamine with a blend of synergistic ingredients, then mixing with water and swishing in the mouth for 10 seconds, the glutamine-disaccharide complex increased glutamine absorption (>100-fold more than glutamine alone) – at the intended site of the mucosal lining,” said Anderson. “Over the years, we found this unique formulation helped prevent and treat mouth sores effectively among patients going through radiation and/or chemotherapy treatment,” he continued.

The dietary supplement helps reduce the severity and duration of oral mucositis, easing the pain of eating and swallowing, making the proper intake of vital nutrition and fluids much easier. Patients going through cancer treatment can take Healios up to twice daily during, and for two weeks after stress periods.

“We are excited to bring Healios to market to help improve the quality of life of patients going through cancer therapy and help them complete their treatment,” said Gillian Isabelle, PhD, CEO of Enlivity. “Our vision is to lead a new product category within the cancer supportive care industry, to address the unmet need of formulated products that are science-backed, available over-the-counter and easy to use – designed to treat side effects in the mouth and gut from cancer treatment,” she continued.

Consumers can now purchase Healios online from Enlivity. Healios is available in two flavors, orange and grape. Except for those with glutamine sensitivities, patients taking Healios have reported no side effects. To order and learn more, visit enlivity.com/healios or call 888-552-9769 or email info@enlivity.com to speak directly with a member of the Enlivity team.

Enlivity, an emerging medical nutrition company based in Boston, Massachusetts is on a mission to improve the oral and digestive health of patients going through cancer treatment. Enlivity provides uniquely formulated, over-the-counter products targeting specific side effects occurring in the mouth and digestive tract that typically result in poor nutritional status. Working with academic and research institutions, oncology health professionals and cancer treatment centers across the country, Enlivity is dedicated to delivering science-backed solutions to help patients continue needed treatments, minimize clinical complications and avoid unplanned hospitalizations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jill Tobacco
Enlivity
+1 (888) 552-9769
Email >
Visit website